Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling

QR Code

Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling

Background: The incidence of esophageal adenocarcinoma (EAC) has increased five-fold in the United States since 1975. The aim of our study was to estimate future U.S. EAC incidence and mortality and to shed light on the potential drivers in the disease process that are conduits for the dramatic incr...

Full description

Bibliographic Details
Main Authors:	Kong, C., Kroep, S., Curtius, K., Hazelton, W., Jeon, J., Meza, R., Heberle, C., Miller, M., Choi, S., Lansdorp_Vogelaar, Iris, Van Ballegooijen, M., Feuer, E., Inadomi, J., Hur, C., Luebeck, E.
Format:	Journal Article
Published:	American Association for Cancer Research Inc 2014
Online Access:	http://hdl.handle.net/20.500.11937/50151

Similar Items

Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis
by: Kroep, S., et al.
Published: (2017)

Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, spain, and the Netherlands
by: Kroep, S., et al.
Published: (2014)

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device
by: Heberle, C., et al.
Published: (2017)

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)

An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling
by: Kroep, S., et al.
Published: (2015)

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)

Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality
by: Etzioni, R., et al.
Published: (2013)

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
by: Secrier, Maria, et al.
Published: (2016)

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)

Esophageal stem cells and genetics/epigenetics in esophageal cancer
by: Croagh, D., et al.
Published: (2014)

State disparities in colorectal cancer mortality patterns in the United States
by: Naishadham, D., et al.
Published: (2011)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)

Calibrating Parameters for Microsimulation Disease Models
by: Van Der Steen, A., et al.
Published: (2015)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

Cost effectiveness of surveillance for GI cancers
by: Omidvari, A., et al.
Published: (2016)

Comparative economic evaluation of data from the ACRIN national CT colonography trial with three cancer intervention and surveillance modeling network microsimulations
by: Vanness, D., et al.
Published: (2011)

Fecal occult blood testing when colonoscopy capacity is limited
by: Wilschut, J., et al.
Published: (2011)

Utilization of surveillance after Polypectomy in the Medicare population - A cohort study
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2014)

Productivity savings from colorectal cancer prevention and control strategies
by: Bradley, C., et al.
Published: (2011)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)

Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)

Personalizing age of cancer screening cessation based on comorbid conditions: Model estimates of harms and benefits
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2014)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)